[Progress on utilizing mesenchymal stem cells as cellular delivery system for targeting delivery of as drug/gene for...

Area of Science:

• Biomedical Engineering
• Oncology
• Cell Biology

Background:

• Mesenchymal stem cells (MSCs) possess inherent tumor-homing abilities due to chemokine attraction from tumor microenvironments.
• Systemically administered MSCs are often initially trapped by the lungs before reaching tumor tissues.

Purpose of the Study:

• To review strategies for improving MSC homing to tumors.
• To summarize the use of MSCs for targeted delivery of anti-cancer drugs and therapeutic genes.
• To explore the potential of MSCs in combined diagnostic and therapeutic applications for cancer.

Main Methods:

• Review of existing literature on MSC-based drug and gene delivery systems.
• Analysis of methods to enhance MSC tumor targeting, including chemokine-receptor interactions and modified administration routes.
• Summary of MSC applications in delivering chemotherapeutics (doxorubicin, paclitaxel, gemcitabine) and therapeutic genes.

Main Results:

• Strategies exist to improve MSC homing efficiency towards tumor sites.
• MSCs can overcome the limitations of traditional chemotherapeutics, such as short half-life and poor targeting.
• MSCs show promise for delivering genes to eliminate tumor cells and modulate the immune system.

Conclusions:

• Optimizing MSC-based delivery systems offers a novel strategy for cancer treatment.
• MSCs serve as versatile cellular carriers for targeted anti-cancer agents.
• Further development of MSC-based delivery holds significant potential for advancing oncology therapies.